Nutritional Insight
  • HOME
  • ABOUT
  • SERVICES
  • PUBLICATIONS
  • INSIGHTS
  • CONTACT
Featured Posts
  • New Diet and Nutrition Survey Data in the UK – Latest Insights.
  • Nutritional Insight – 2020 Roundup
  • Webinar Wisdoms
  • Choline, Neurological Development and Brain Function: A  Focus on the First 1000 Days

  • Is there Scope for a Novel Mycelium Category of Proteins alongside Animals and Plants?

  • Is there a Role for Immunonutrition in the Over 65s?

  • COVID-19 and Why the Aged Should be Swiftly reminded to take their Vitamin D.
  • Genome-Edited Foods: Are they Coming to our Supermarkets Soon?
  • Green and Blue Water Footprints: What Are They & How Do They Relate to Food?
  • Stress and Micronutrient Concentrations: Do They Impact Each Other?
  • HOME
  • ABOUT
  • SERVICES
  • PUBLICATIONS
  • INSIGHTS
  • CONTACT
Followers
Subscribe
Nutritional Insight
Nutritional Insight
  • HOME
  • ABOUT
  • SERVICES
  • PUBLICATIONS
  • INSIGHTS
  • CONTACT
  • All
  • Drug Production
  • Eggs
  • Novel Methods
  • Uncategorized

Chicken’s Laying Eggs with Human Proteins: Development of a Novel Cost Effective Method of Drug Production

  • Posted on March 6, 2019March 6, 2019
Total
0
Shares
0
0

Genetically modified chickens have been developed at the University of Edinburgh’s Roslin Institute to produce human proteins in their eggs, which is hoped can offer a cost-effective method of producing drugs. These human proteins can be recovered in high quantities using a simple purification system and have been shown to be as effective as proteins produced using the existing more expensive methods.

Here we report the efficient generation of new transgenic chicken lines to optimize protein production in eggs. As proof-of-concept, the expression, purification and functional characterisation has been described of three pharmaceutical proteins, the human cytokine interferon α2a and two species-specific Fc fusions of the cytokine CSF1.

Why Do We Need New Methods of Drug Production?

Currently, protein-based drugs are mainly produced utilising mammalian cell culture techniques. These methods of production are expensive and are generally produced only in low yields, as such the production of protein-based drugs is compromised by the high cost of manufacture and validation compared to traditional chemical drugs. In addition, current methods of drug production require complex purification systems and additional processing techniques, which in turn increases production costs.

It is thus imperative that novel, cheaper, cost-effective methods are needed for the production of drugs in high yields. Improvements in transgenic technologies will allow valuable proteins to be produced by genetically-modified animals and the production of therapeutic proteins in egg white of transgenic chickens would considerably lower costs across the whole production cycle in comparison to traditional cell culture-based production systems. This could lead to more affordable treatments and broader markets, such as in developing countries and animal health applications.

Towards Developing Eggs for the Production of Drugs

Scientists have previously produced genetically modified animals, such as goats, chickens and rabbits. They have shown that the milk or eggs of these animals can be utilised in the production of protein therapies/drugs. Scientists at the Roslin Institute propose that their novel method utilising chicken eggs is more efficient, produces better yields and is more cost-effective than these previous attempts. In fact, only three eggs were enough to produce a clinically relevant dose of the drug. Chickens are able to lay up to 300 eggs per year, and as such this novel approach should be more cost-effective that current production methods in the production of important drugs to treat cancer and other diseases.

Currently, scientists at the Roslin Institute are focusing on producing high quality proteins for use in scientific research and have observed no adverse effects on the chickens themselves, which lay eggs as normal. The scientists have initially focused on two proteins that are essential to the immune system and have therapeutic potential. (1). A human cytokine interferon alpha 2a, which has powerful antiviral and anti-cancer effects, and (2). The human and pig versions of the cytokine macrophage-CSF1, which is being developed as a therapy that stimulates damaged tissues to repair themselves. Initial studies have shown a proof-of-principle for the system, which is deemed feasible and as such could easily be adapted to produce other therapeutic proteins.

Egg-Based Flu Vaccines

Eggs are already used for growing viruses that are used as vaccines. For more than 70 years, the flu vaccine has been most commonly produced using an egg-based manufacturing process. Egg-based vaccine manufacturing is used to make both inactivated vaccines, the flu injection, and live attenuated vaccines, the flu nasal spray. Candidate vaccine viruses (CVVs) are injected into fertilised chicken’s eggs and incubated for several days to allow the viruses to replicate and then the virus-containing fluid is harvested from the eggs. The production of egg-based flu vaccines is different to the new approach being developed at the Roslin Institute as the therapeutic proteins are encoded in the chicken’s DNA and produced as part of the egg white.

What does the Future Hold?

This method is currently not being utilised for the production of drugs or medicines for use in humans, as it is still undergoing development. However, studies are showing that chickens are commercially viable for the production of high quality drugs cost effectively. The proteins produced via this novel method have applications in drug discovery studies, biotechnology applications, research studies and hopefully, one day, in patients. In essence, this work validates a transgenic chicken system for the cost-effective production of pure, high quality, biologically active protein for therapeutics and other applications.

References:

Herron LR et al (2018) A chicken bioreactor for efficient production of functional cytokines. BMC Biotechnology. Dec 29; 18(1):82.

https://www.ed.ac.uk/roslin/news-events/latest-news/hen-eggs-human-proteins-drug-hope

https://www.cdc.gov/flu/protect/vaccine/how-fluvaccine-made.htm#egg

 

Total
0
Shares
Tweet 0
Share 0
Related Topics
  • Drug production
  • Eggs
  • Novel methods
Nutritional Insight

Previous Article
  • All
  • Guidelines
  • Supplements
  • Surveillance
  • Uncategorized

Dietary Supplement Use among Infants: An Insight into US National Health and Nutrition Examination Survey Findings.

  • Posted on March 6, 2019March 6, 2019
View Post
Next Article
  • All
  • Brexit
  • Nutrition Exit
  • Regulations
  • Uncategorized

Nutrition EU Exit Regulations: Response from the Food Manufacturing and Nutrition Industry

  • Posted on March 6, 2019March 6, 2019
View Post
You May Also Like
View Post
  • All

Webinar Wisdoms

  • Posted on September 24, 2020September 24, 2020
View Post
  • All

COVID-19 and Why the Aged Should be Swiftly reminded to take their Vitamin D.

  • Posted on March 20, 2020
View Post
  • All

Genome-Edited Foods: Are they Coming to our Supermarkets Soon?

  • Posted on February 3, 2020
View Post
  • All

Green and Blue Water Footprints: What Are They & How Do They Relate to Food?

  • Posted on November 4, 2019November 4, 2019
View Post
  • All

Stress and Micronutrient Concentrations: Do They Impact Each Other?

  • Posted on November 4, 2019November 4, 2019
View Post
  • All

Does the Nutrition Education of Physicians Need Advancing?

  • Posted on September 27, 2019September 27, 2019
View Post
  • All

Palm Oil: Should it Be Given the Same Attention as Single Use Plastics?

  • Posted on September 27, 2019September 27, 2019
View Post
  • All

Folic Acid Fortification: Assessing the Folate Status of Women After 20 Years of Fortification in the US

  • Posted on September 27, 2019September 27, 2019
Categories
  • 2020
  • 2021
  • about
  • All
  • Allergy
  • Before Pregnancy
  • Brain Health
  • Brexit
  • Calories
  • Cardiovascular Disease
  • Children
  • Children's Health
  • choline
  • Clean Labelling
  • Conception
  • Depression
  • Diabetes
  • Dietary Patterns
  • Drug Production
  • Eggs
  • Environutrition
  • Evidence-base
  • Fertility
  • Folic Acid
  • food and nutrition trends
  • Food Processing
  • Future Directions
  • Growing Up
  • Guidelines
  • Health
  • health trends
  • Marketing
  • Medical Diet
  • Microbiota
  • Micronutrients
  • Mid-Life
  • Mycoprotein
  • Novel Methods
  • Nutrition
  • Nutrition Exit
  • Nutrition Science
  • nutrition trends
  • nutritional insight
  • Obesity
  • Omega
  • Palm Oil
  • PEER-REVIEWED PUBLICATIONS
  • Planetary Health
  • Probiotics
  • Protein Distribution
  • Protein Quality
  • Protein Shift
  • Puddings
  • Regulations
  • Research
  • Sugar
  • Supplements
  • Surveillance
  • Sustainable Eating
  • Sweet cherries
  • Tea
  • The Fast 800
  • Ultra Processing
  • Uncategorized
  • Vertical Farming
Featured Posts
  • Webinar Wisdoms
  • Choline, Neurological Development and Brain Function: A  Focus on the First 1000 Days

  • Is there Scope for a Novel Mycelium Category of Proteins alongside Animals and Plants?

  • Is there a Role for Immunonutrition in the Over 65s?

  • COVID-19 and Why the Aged Should be Swiftly reminded to take their Vitamin D.
Subscription Form
Keep Up to Date
Design By
SEVENTEEN
Frequently Searched
ADHD Almonds Antibiotic resistance Assessment Brexit Cardiac Health Children Choline Chrono-Nutrition Chronotype COVID-19 Depression Drug production Eggs Evidence-base Folic Acid Future of Nutrition Future Trends Growing Up Guidelines Health Health Science Information Era Microbiota micronutrients Minerals Novel methods Nutritional Profiling Nutrition and Health Claims Nutrition Exit Omega Orthorexia Polyphenols Precision Nutrition Protein Distribution Protein Quality Ratios Red Meat Registered Nutritionists Regulations Supplements Synergy Vertical Farming Vitamin D Vitamins
Nutritional Insight
  • HOME
  • ABOUT
  • SERVICES
  • PUBLICATIONS
  • INSIGHTS
  • CONTACT

Input your search keywords and press Enter.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.